Another study [132] showcased BGs’ potential as a tumor vaccine platform, effectively stimulating DC cell maturation and displaying superior activation of CD8+ T cells compared to LPS and IFN-γ-induced groups. This evidence concerns the gene CD8A and neoplasm.